Posts Tagged ‘nasdaq’

AMRN flies on positive tests, C sells widely, CEU staggers

Monday, November 29th, 2010

Amarin Corp. PLC (NasdaqCM: AMRN) enjoyed a gain of gained 58.03 percent in price early Monday to $5.61. Volume in the first hour was a staggering 17,200,902 shares, trampling its three-month average share volume of 767,131. The Connecticut and Ireland-based pharmaceutical company today reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 clinical trial of lead drug candidate AMR101.

Citigroup Inc. (NYSE: C) was among Monday morning’s volume leaders, trading in 104,926,884 shares, nearly a quarter of its normal daily volume of 117,592,265 shares, with its three-month average share volume pegged at 464,971,000. The banking behemoth upped its price by 0.97 percent to $4.15. C today announced that it has won a mandate to provide third-party securities lending services for Global X Funds’ family of exchange traded funds.

China Education Alliance Inc. (NYSE: CEU) fell in price early Tuesday by 12.7 percent to $3.85. Volume was 165,878 shares, its three-month average share volume not available at press time. CEU is a leading China-based company experiencing fast-growing, offering high-quality education resources and services to students ages 6 to 18 and adults (university students and professionals) ages 18 and over.

END ends well, YHOO trades widely, BBXT fades

Thursday, November 18th, 2010

Endeavor International Corporation (NYSE: END) gained 4.4 percent in price in Thursday afternoon trade to close at $8.77 Volume of 102,795 shares was below its usual share volume of 564,506. The Houston-based oil and gas exploration and production company announced Wednesday a one-for-seven share consolidation.

Yahoo Corp. (NasdaqGS: YHOO) was among Thursday’s volume leaders, trading in 45,688,242 shares Thursday afternoon, nearly doubling its usual daily volume of 23,853,700 shares. Shares of the search engine company surge 5.2 percent to close at $16.99. Wednesday, Tippr, which operates Tippr.com, one of the largest group buying sites on the Internet, today announced a partnership with Yahoo!, Inc. to feature Tippr.com deals on Yahoo!’s new Local Offers program.

BankAtlantic Bancorp Inc. (NasdaqGM: BBXT) fell in price Thursday by 14.55 percent to $7.39. Volume of 24,799 shares was more than eight times the company’s usual daily volume.

NYNY comes up nuggets, MSFT big trader, LPTH slides

Thursday, November 18th, 2010

Empire Resorts Inc. (NasdaqGM: NYNY) gained 25.83 percent in price in Thursday afternoon trade to $1.51 Volume of 1,969,508 shares left its usual share volume of 164,241 in the dust. The casino operator announced last week that its wholly-owned subsidiary, Monticello Casino and Raceway, has added electronic roulette games to its increasingly diverse slot offerings.

Microsoft Corp. (NasdaqGS: MSFT) was among Thursday’s volume kingpins, trading in 46,986,893 shares Thursday afternoon, approaching its usual daily volume of 61,528,900 shares. Shares of the software giant inched up 1.17 percent to $25.87. Following the successful launch of Microsoft Dynamics GP 2010, MSFT announced Thursday that the upcoming release of Microsoft Dynamics GP 2010 R2 will provide midsize customers with new contextual business intelligence capabilities and additional ease-of-use features that make actionable information more accessible than before to people across an organization.

LightPath Technologies Inc. (NasdaqCM: LPTH) fell in price Thursday by 12.61 percent to $1.97. Volume of 56,602 shares narrowly bested the company’s usual daily volume of 39,762 shares. The Orlando-based global manufacturer, distributor and integrator of patented optical components and assemblies announced Wednesday that it has expanded its direct selling channels in China as part of its strategy to deliver high volumes of aspheric lenses to Asian manufacturers of optical equipment.

BORN soars in price, INTC big seller, UQM sinks

Thursday, November 18th, 2010

China New Borun Corporation (NYSE: BORN) saw a spike in price of 11.8 percent in Thursday afternoon trade to $12.41 Volume of 903,056 shares is to within sight of its daily average of 1,246,800 shares. The Beijing-based producer and distributor of corn-based edible alcohol in China, this week announced third-quarter revenue increased 26.1 percent to RMB417.7 million ($62.3 million U.S.) from RMB331.1 million in the third quarter of 2009. Gross profit increased 31.2 percent to RMB100.9 million ($15.1 million).

Intel Corp. (NasdaqGS: INTC) traded in 48,084,401 shares Thursday afternoon, approaching its usual daily volume of 67,954,000 shares. Shares of the chipmaker fell back 0.38 percent to $21.00. The company announced its storage division has recently added new major wins with five storage vendors, illustrating the company’s momentum around developing advanced integrated storage features and capabilities.

UQM Technologies Inc. (AMEX: UQM) fell in price Thursday by 3.81 percent to $2.02. Volume of 224,907 shares was still shy of UQM’s usual daily volume of 281, 265 shares. The Colorado-based UQM develops of alternative energy technologies.

EX excels, SIRI dishes widely, ASTM falls

Thursday, November 18th, 2010

Exelixis Inc. (NasdaqGS: EXEL) improved in price by 29.66 percent in Thursday afternoon trade to $6.12 Volume of 11,806,150 shares proved about 12 times the stock’s three-month daily average. The drug maker Thursday reported interim data from the cohort of patients with advanced epithelial ovarian cancer, primary peritoneal, or fallopian tube carcinoma treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

Sirius XM Radio Inc. (NasdaqGS: SIRI) was a volume leader Thursday afternoon, with 47,602,492 shares changing hands, against its usual daily volume of 75,126,200 shares. SIRI shares added 3.70 percent Thursday in price to $1.40.

Aastrom Biosciences Inc. (NasdaqCM: ASTM) fell in price Thursday by 22.14 percent to $3.27. Volume of 4,182,850 shares trampled over usual daily volume of 1,068,090 shares. The Michigan-based developer of expanded autologous cellular therapies today announced that an interim analysis of all 86 patients enrolled in the company’s Phase 2b RESTORE-CLI clinical trial shows that the study achieved both its primary safety endpoint and primary efficacy endpoint of time to first occurrence of treatment failure.